8-KItem 2.02 · Results of OperationsItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Bristol-Myers Squibb ($BMY) issued a press release on Feb 5, 2026 announcing Q4 & full‑year 2025 financial…
Filed with the SEC on · Summarized by InvestorsBot
Bristol-Myers Squibb ($BMY) issued a press release on Feb 5, 2026 announcing Q4 & full‑year 2025 financial results. Earnings Press Release is posted at www.bms.com and furnished as Exhibit 99.1 to this Form 8‑K. 🗓️📄 #earnings #pharma
The Feb 5, 2026 press release (Exhibit 99.1) is the only website content incorporated by reference into this 8‑K; other material on the company website is not incorporated. $BMY 🔍 #SEC #8K
Investors should review Exhibit 99.1 on the BMS site or the Form 8‑K for the full Q4 and FY2025 results filed Feb 5, 2026. $BMY 📈 #earnings #investing